RNA therapeutics promise rapid, personalized and flexible treatments against multiple diseases. In this article, we will ...

In a paper published in Science Bulletin, a Chinese team of scientists made a significant breakthrough in major depressive ...

Orna, a circular RNA startup, acquired ReNAgade earlier this year in a deal meant to access the Cambridge company’s technology for delivering RNA medicines. Now, Orna says the newly combined ...

Circular RNA (circRNA) is gaining increasing attention due to its stable structure, its role in gene regulation, and more recently, its involvement in regulatory circuits mediated by other non-coding ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development ...

Obelisks are simpler than viruses, consisting of a stretched circular molecule with about a thousand letters of RNA. They are infectious agents that appear to colonize some bacteria in the mouths and ...

Conventional targeted RNA-seq methods often require labor-intensive ... non-polyadenylated, and circular RNAs. It also integrates an EM-based model to achieve unbiased transcriptome quantification ...

“We were able to resolve this challenge by relying heavily on market research, data, and applying our learnings from our other successful platforms and work we accomplished in the circular RNA ...

The Next Generation RNA Therapeutics Summit comes to Boston on May 24-26 to unite experts to discuss how novel modalities from self-replicating to circular RNAs have the potential to overcome key ...